Literature DB >> 2576096

Diversity of the outer membrane protein P2 gene from major clones of Haemophilus influenzae type b.

R Munson1, C Bailey, S Grass.   

Abstract

In previous studies, it has been demonstrated that outer membrane protein P2 from Haemophilus influenzae type b has porin activity and that antibody directed against P2 is protective in an infant rat bacteraemic model. Outer membrane protein subtyping has been employed to subclassify type b Haemophilus isolates. Strain MinnA has the outer membrane protein subtype 1H and is representative of the dominant clonal group of disease-producing isolates in the United States. In the present study, the P2 gene from strain MinnA was employed to probe EcoRI- and Pvull-digested chromosomal DNA from 24 Haemophilus influenzae type b isolates representative of the common outer membrane protein subtype groups observed throughout the world. Restriction fragment length polymorphisms were identified for the members of the outer membrane protein subtype 3L group, but not for the other subtypes examined. The P2 gene from each of four prototype isolates was then cloned, sequenced and compared to the previously reported sequence of the strain MinnA gene. The P2 gene from each of two isolates with the outer membrane protein subtype 3L was identical to the MinnA P2 sequence. The P2 gene from a subtype 2L isolate differed by a single nucleotide and the gene from a subtype 6U isolate differed by 13 nucleotides. Thus, the P2 protein is highly conserved among type b isolates.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2576096     DOI: 10.1111/j.1365-2958.1989.tb00165.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  17 in total

1.  Antigenic sites on porin of Haemophilus influenzae type b: mapping with synthetic peptides and evaluation of structure predictions.

Authors:  R Srikumar; D Dahan; M F Gras; M J Ratcliffe; L van Alphen; J W Coulton
Journal:  J Bacteriol       Date:  1992-06       Impact factor: 3.490

2.  Identification of two iron-repressed periplasmic proteins in Haemophilus influenzae.

Authors:  R E Harkness; P Chong; M H Klein
Journal:  J Bacteriol       Date:  1992-04       Impact factor: 3.490

3.  Antigenic relationships among the porin proteins of encapsulated Haemophilus influenzae clones.

Authors:  D Martin; J Hamel; B R Brodeur; J M Musser
Journal:  J Clin Microbiol       Date:  1990-08       Impact factor: 5.948

4.  Antigenic characterization and analysis of the human immune response to outer membrane protein E of Branhamella catarrhalis.

Authors:  R Bhushan; C Kirkham; S Sethi; T F Murphy
Journal:  Infect Immun       Date:  1997-07       Impact factor: 3.441

5.  Potential of a novel protein, OMP26, from nontypeable Haemophilus influenzae to enhance pulmonary clearance in a rat model.

Authors:  J M Kyd; A W Cripps
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

6.  Molecular cloning, expression, and sequence of the pilin gene from nontypeable Haemophilus influenzae M37.

Authors:  T Coleman; S Grass; R Munson
Journal:  Infect Immun       Date:  1991-05       Impact factor: 3.441

7.  Reconstitution of a porin-deficient mutant of Haemophilus influenzae type b with a porin gene from nontypeable H. influenzae.

Authors:  J D Sanders; L D Cope; G P Jarosik; I Maciver; J L Latimer; G B Toews; E J Hansen
Journal:  Infect Immun       Date:  1993-09       Impact factor: 3.441

8.  Diversity of the P2 protein among nontypeable Haemophilus influenzae isolates.

Authors:  J Bell; S Grass; D Jeanteur; R S Munson
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

9.  Molecular analysis of the P2 porin protein of nontypeable Haemophilus influenzae.

Authors:  D J Sikkema; T F Murphy
Journal:  Infect Immun       Date:  1992-12       Impact factor: 3.441

10.  Affinity, conservation, and surface exposure of hemopexin-binding proteins in Haemophilus influenzae.

Authors:  J C Wong; R Patel; D Kendall; P W Whitby; A Smith; J Holland; P Williams
Journal:  Infect Immun       Date:  1995-06       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.